Entrada Therapeutics Overview
Entrada Therapeutics Target Price
Analysts' 12-month price predictions for TRDA.
Get informed when a big investor buys or sells
+ FollowShare Price
$7.72
Average Target Price
$13.50
74.9% upside
74.9% upside2 analysts in the last 4 months
High: $17 | Low: $10
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-08 | Guggenheim | $17 | 120.2% upside |  |
| 2026-05-08 | Roth Capital | $10 | 29.5% upside | |
| 2026-02-10 | Guggenheim | $20 | 159.1% upside | |
| 2026-01-28 | OppenheimerKostas Biliouris | $21 | 172% upside | |
| 2025-11-06 | Roth Capital | $13 | 68.4% upside | |
| 2025-02-28 | Roth Capital | $23 | 197.9% upside | |
| 2024-11-06 | H.C. WainwrightBoobalan Pachaiyappan | $20 | 159.1% upside | |
| 2024-06-25 | H.C. WainwrightRaghuram Selvaraju | $18 | 133.2% upside | |